Literature DB >> 20647584

Understanding late gadolinium enhancement in pulmonary hypertension.

William M Bradlow1, Ravi Assomull, Philip J Kilner, J Simon R Gibbs, Mary N Sheppard, Raad H Mohiaddin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20647584     DOI： 10.1161/CIRCIMAGING.109.919779

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  24 in total

1.  Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts.

Authors:  Chrysanthos Grigoratos; Adriana Pantano; Maria Meschisi; Raffaella Gaeta; Lamia Ait-Ali; Andrea Barison; Giancarlo Todiere; Pierluigi Festa; Gianfranco Sinagra; Giovanni Donato Aquaro
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-06       Impact factor: 2.357

2.  Lifelong Physical Activity Regardless of Dose Is Not Associated With Myocardial Fibrosis.

Authors:  Shuaib M Abdullah; Kyler W Barkley; Paul S Bhella; Jeffrey L Hastings; Susan Matulevicius; Naoki Fujimoto; Shigeki Shibata; Graeme Carrick-Ranson; M Dean Palmer; Nainesh Gandhi; Laura F DeFina; Benjamin D Levine
Journal:  Circ Cardiovasc Imaging       Date:  2016-11       Impact factor: 7.792

3.  Cardiovascular magnetic resonance in pulmonary hypertension.

Authors:  William M Bradlow; J Simon R Gibbs; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-01-18       Impact factor: 5.364

4.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

5.  Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults.

Authors:  Sujata M Shanbhag; Anders M Greve; Thor Aspelund; Erik B Schelbert; J Jane Cao; Ragnar Danielsen; Guðmundur Þorgeirsson; Sigurður Sigurðsson; Guðný Eiríksdóttir; Tamara B Harris; Lenore J Launer; Vilmundur Guðnason; Andrew E Arai
Journal:  Eur Heart J       Date:  2019-02-07       Impact factor: 29.983

6.  Potential Value of Native T1 Mapping in Symptomatic Adults with Congenital Heart Disease: A Preliminary Study of 3.0 Tesla Cardiac Magnetic Resonance Imaging.

Authors:  Yumi Shiina; Kei Inai; Kota Taniguchi; Tatsunori Takahashi; Michinobu Nagao
Journal:  Pediatr Cardiol       Date:  2019-10-25       Impact factor: 1.655

7.  Does Late Gadolinium Enhancement still have Value? Right Ventricular Internal Mechanical Work, Ea/Emax and Late Gadolinium Enhancement as Prognostic Markers in Patients with Advanced Pulmonary Hypertension via Cardiac MRI.

Authors:  Amr Ei Abouelnour; Mark Doyle; Diane V Thompson; June Yamrozik; Ronald B Williams; Moneal B Shah; Siva Kr Soma; Srinivas Murali; Raymond L Benza; Robert Ww Biederman
Journal:  Cardiol Res Cardiovasc Med       Date:  2017-01-11

8.  Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases.

Authors:  Jing Wang; Hang Zhao; Yue Wang; Howard C Herrmann; Walter R T Witschey; Yuchi Han
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.

Authors:  Mohamad Amer Alaiti; Aditya Goud; Gautam Ramani; Sashwatee Bagchi; Sadeer Al-Kindi; Steven Sawicki; Christopher Longenecker; Trevor Jenkins; David Pauza; Myung Park; Grace McComsey; Orlando Simonetti; Brian Hoit; Sanjay Rajagopalan
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-11       Impact factor: 2.160

Review 10.  Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art.

Authors:  Andrew J Swift; Jim M Wild; Scott K Nagle; Alejandro Roldán-Alzate; Christopher J François; Sean Fain; Kevin Johnson; Dave Capener; Edwin J R van Beek; David G Kiely; Kang Wang; Mark L Schiebler
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.